pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-2116 |
Genomic Coordinates | chr15: 59171183 - 59171262 |
Description | Homo sapiens miR-2116 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-2116-3p | |||||||||||||||||||||
Sequence | 51| CCUCCCAUGCCAAGAACUCCC |71 | |||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||
Experiments | 454 | |||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TXNIP | ||||||||||||||||||||
Synonyms | ARRDC6, EST01027, HHCPA78, THIF, VDUP1 | ||||||||||||||||||||
Description | thioredoxin interacting protein | ||||||||||||||||||||
Transcript | NM_006472 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TXNIP | |||||||||||||||||||||
3'UTR of TXNIP (miRNA target sites are highlighted) |
>TXNIP|NM_006472|3'UTR 1 GCATGTGGAAGAAAAGAAGCAGCTTTACCTACTTGTTTCTTTTTGTCTCTCTTCCTGGACACTCACTTTTTCAGAGACTC 81 AACAGTCTCTGCAATGGAGTGTGGGTCCACCTTAGCCTCTGACTTCCTAATGTAGGAGGTGGTCAGCAGGCAATCTCCTG 161 GGCCTTAAAGGATGCGGACTCATCCTCAGCCAGCGCCCATGTTGTGATACAGGGGTGTTTGTTGGATGGGTTTAAAAATA 241 ACTAGAAAAACTCAGGCCCATCCATTTTCTCAGATCTCCTTGAAAATTGAGGCCTTTTCGATAGTTTCGGGTCAGGTAAA 321 AATGGCCTCCTGGCGTAAGCTTTTCAAGGTTTTTTGGAGGCTTTTTGTAAATTGTGATAGGAACTTTGGACCTTGAACTT 401 ACGTATCATGTGGAGAAGAGCCAATTTAACAAACTAGGAAGATGAAAAGGGAAATTGTGGCCAAAACTTTGGGAAAAGGA 481 GGTTCTTAAAATCAGTGTTTCCCCTTTGTGCACTTGTAGAAAAAAAAGAAAAACCTTCTAGAGCTGATTTGATGGACAAT 561 GGAGAGAGCTTTCCCTGTGATTATAAAAAAGGAAGCTAGCTGCTCTACGGTCATCTTTGCTTAGAGTATACTTTAACCTG 641 GCTTTTAAAGCAGTAGTAACTGCCCCACCAAAGGTCTTAAAAGCCATTTTTGGAGCCTATTGCACTGTGTTCTCCTACTG 721 CAAATATTTTCATATGGGAGGATGGTTTTCTCTTCATGTAAGTCCTTGGAATTGATTCTAAGGTGATGTTCTTAGCACTT 801 TAATTCCTGTCAAATTTTTTGTTCTCCCCTTCTGCCATCTTAAATGTAAGCTGAAACTGGTCTACTGTGTCTCTAGGGTT 881 AAGCCAAAAGACAAAAAAAATTTTACTACTTTTGAGATTGCCCCAATGTACAGAATTATATAATTCTAACGCTTAAATCA 961 TGTGAAAGGGTTGCTGCTGTCAGCCTTGCCCACTGTGACTTCAAACCCAAGGAGGAACTCTTGATCAAGATGCCCAACCC 1041 TGTGATCAGAACCTCCAAATACTGCCATGAGAAACTAGAGGGCAGGTCTTCATAAAAGCCCTTTGAACCCCCTTCCTGCC 1121 CTGTGTTAGGAGATAGGGATATTGGCCCCTCACTGCAGCTGCCAGCACTTGGTCAGTCACTCTCAGCCATAGCACTTTGT 1201 TCACTGTCCTGTGTCAGAGCACTGAGCTCCACCCTTTTCTGAGAGTTATTACAGCCAGAAAGTGTGGGCTGAAGATGGTT 1281 GGTTTCATGTTTTTGTATTATGTATCTTTTTGTATGGTAAAGACTATATTTTGTACTTAACCAGATATATTTTTACCCCA 1361 GATGGGGATATTCTTTGTAAAAAATGAAAATAAAGTTTTTTTAATGGAAAAAAAAATGTCTGTGAAAAAAAAAAAAAAAA 1441 AA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 10628.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000369317.4 | 3UTR | CCAUUUUUGGAGCCUAUUGCACUGUGUUCUCCUACUGCAAAUAUUUUCAUAUGGGAGGAUGGUUUUCUCUUCAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000369317.4 | 3UTR | CCAUUUUUGGAGCCUAUUGCACUGUGUUCUCCUACUGCAAAUAUUUUCAUAUGGGAGGAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000369317.4 | 3UTR | CCUAUUGCACUGUGUUCUCCUACUGCAAAUAUUUUCAUAUGGGAGGAUGGUUUUCUCUUCAUGUAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
152 hsa-miR-2116-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052654 | PLA2G4F | phospholipase A2 group IVF | 1 | 1 | ||||||||
MIRT064886 | ZBTB18 | zinc finger and BTB domain containing 18 | 2 | 2 | ||||||||
MIRT130162 | TXNIP | thioredoxin interacting protein | 2 | 6 | ||||||||
MIRT222068 | PURB | purine rich element binding protein B | 2 | 4 | ||||||||
MIRT232512 | MBD6 | methyl-CpG binding domain protein 6 | 2 | 2 | ||||||||
MIRT243458 | LMLN | leishmanolysin like peptidase | 2 | 2 | ||||||||
MIRT461322 | MRPS27 | mitochondrial ribosomal protein S27 | 2 | 2 | ||||||||
MIRT493800 | GAN | gigaxonin | 2 | 6 | ||||||||
MIRT495019 | C2CD4B | C2 calcium dependent domain containing 4B | 2 | 2 | ||||||||
MIRT497481 | XPR1 | xenotropic and polytropic retrovirus receptor 1 | 2 | 2 | ||||||||
MIRT497542 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT504017 | ACSL6 | acyl-CoA synthetase long chain family member 6 | 2 | 2 | ||||||||
MIRT504762 | TEP1 | telomerase associated protein 1 | 2 | 4 | ||||||||
MIRT504833 | EREG | epiregulin | 2 | 2 | ||||||||
MIRT505554 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 | 2 | 2 | ||||||||
MIRT506088 | PPM1A | protein phosphatase, Mg2+/Mn2+ dependent 1A | 2 | 2 | ||||||||
MIRT513389 | TUBB4A | tubulin beta 4A class IVa | 2 | 2 | ||||||||
MIRT521643 | PROSC | pyridoxal phosphate binding protein | 2 | 2 | ||||||||
MIRT525286 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 2 | ||||||||
MIRT525334 | CNGB1 | cyclic nucleotide gated channel beta 1 | 2 | 2 | ||||||||
MIRT525789 | SOD2 | superoxide dismutase 2 | 2 | 2 | ||||||||
MIRT526169 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT526759 | GATS | GATS, stromal antigen 3 opposite strand | 2 | 2 | ||||||||
MIRT527223 | C3orf36 | chromosome 3 open reading frame 36 | 2 | 4 | ||||||||
MIRT527423 | NRL | neural retina leucine zipper | 2 | 2 | ||||||||
MIRT528795 | RAB32 | RAB32, member RAS oncogene family | 2 | 2 | ||||||||
MIRT529002 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 4 | ||||||||
MIRT529792 | AP4S1 | adaptor related protein complex 4 sigma 1 subunit | 2 | 2 | ||||||||
MIRT530236 | PLXDC1 | plexin domain containing 1 | 2 | 2 | ||||||||
MIRT530511 | C4orf32 | family with sequence similarity 241 member A | 2 | 2 | ||||||||
MIRT530805 | GPR182 | G protein-coupled receptor 182 | 2 | 2 | ||||||||
MIRT531301 | GPR26 | G protein-coupled receptor 26 | 2 | 2 | ||||||||
MIRT534309 | SKIDA1 | SKI/DACH domain containing 1 | 2 | 2 | ||||||||
MIRT535303 | PHF12 | PHD finger protein 12 | 2 | 2 | ||||||||
MIRT544454 | KRBOX4 | KRAB box domain containing 4 | 2 | 2 | ||||||||
MIRT547160 | PDZD8 | PDZ domain containing 8 | 2 | 2 | ||||||||
MIRT548160 | FRAT2 | FRAT2, WNT signaling pathway regulator | 2 | 2 | ||||||||
MIRT551675 | BBS5 | Bardet-Biedl syndrome 5 | 2 | 2 | ||||||||
MIRT551692 | ASB16 | ankyrin repeat and SOCS box containing 16 | 2 | 2 | ||||||||
MIRT555855 | PAPD4 | poly(A) RNA polymerase D4, non-canonical | 2 | 2 | ||||||||
MIRT566196 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT569417 | TRAF3IP2 | TRAF3 interacting protein 2 | 2 | 2 | ||||||||
MIRT570779 | ZNF468 | zinc finger protein 468 | 2 | 2 | ||||||||
MIRT572902 | RUNDC3B | RUN domain containing 3B | 2 | 2 | ||||||||
MIRT607664 | BTN3A2 | butyrophilin subfamily 3 member A2 | 2 | 2 | ||||||||
MIRT608835 | PTCHD1 | patched domain containing 1 | 2 | 2 | ||||||||
MIRT610299 | KLHL21 | kelch like family member 21 | 2 | 2 | ||||||||
MIRT610318 | CBY3 | chibby family member 3 | 2 | 2 | ||||||||
MIRT615460 | REPS1 | RALBP1 associated Eps domain containing 1 | 2 | 2 | ||||||||
MIRT618287 | ZNF682 | zinc finger protein 682 | 2 | 2 | ||||||||
MIRT619077 | DNAAF3 | dynein axonemal assembly factor 3 | 2 | 2 | ||||||||
MIRT620181 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT621543 | ZNF500 | zinc finger protein 500 | 2 | 2 | ||||||||
MIRT621619 | UHRF1BP1L | UHRF1 binding protein 1 like | 2 | 2 | ||||||||
MIRT621719 | TRAPPC10 | trafficking protein particle complex 10 | 2 | 2 | ||||||||
MIRT622715 | PLEKHA2 | pleckstrin homology domain containing A2 | 2 | 2 | ||||||||
MIRT625679 | SYAP1 | synapse associated protein 1 | 2 | 2 | ||||||||
MIRT626059 | AP3M1 | adaptor related protein complex 3 mu 1 subunit | 2 | 2 | ||||||||
MIRT626152 | NFYA | nuclear transcription factor Y subunit alpha | 2 | 2 | ||||||||
MIRT626172 | DNAJB13 | DnaJ heat shock protein family (Hsp40) member B13 | 2 | 2 | ||||||||
MIRT629678 | MYO1F | myosin IF | 2 | 2 | ||||||||
MIRT629821 | REL | REL proto-oncogene, NF-kB subunit | 2 | 2 | ||||||||
MIRT630641 | ELK1 | ELK1, ETS transcription factor | 2 | 2 | ||||||||
MIRT631231 | C7orf65 | chromosome 7 open reading frame 65 | 2 | 2 | ||||||||
MIRT633344 | GRK4 | G protein-coupled receptor kinase 4 | 2 | 2 | ||||||||
MIRT633552 | ATAD3C | ATPase family, AAA domain containing 3C | 2 | 2 | ||||||||
MIRT633595 | CFHR5 | complement factor H related 5 | 2 | 2 | ||||||||
MIRT635442 | SLC25A44 | solute carrier family 25 member 44 | 2 | 2 | ||||||||
MIRT636490 | GRIN2B | glutamate ionotropic receptor NMDA type subunit 2B | 2 | 2 | ||||||||
MIRT636867 | ARSE | arylsulfatase E (chondrodysplasia punctata 1) | 2 | 2 | ||||||||
MIRT637180 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT638726 | FOXK1 | forkhead box K1 | 2 | 2 | ||||||||
MIRT638921 | CALCOCO2 | calcium binding and coiled-coil domain 2 | 2 | 2 | ||||||||
MIRT639830 | ZKSCAN1 | zinc finger with KRAB and SCAN domains 1 | 2 | 2 | ||||||||
MIRT641013 | ANKFY1 | ankyrin repeat and FYVE domain containing 1 | 2 | 2 | ||||||||
MIRT641817 | ULK2 | unc-51 like autophagy activating kinase 2 | 2 | 2 | ||||||||
MIRT641966 | PWWP2A | PWWP domain containing 2A | 2 | 2 | ||||||||
MIRT643596 | SPAG16 | sperm associated antigen 16 | 2 | 2 | ||||||||
MIRT643684 | AMER3 | APC membrane recruitment protein 3 | 2 | 2 | ||||||||
MIRT644453 | ALDOC | aldolase, fructose-bisphosphate C | 2 | 2 | ||||||||
MIRT645278 | SLC38A5 | solute carrier family 38 member 5 | 2 | 2 | ||||||||
MIRT646676 | CCDC69 | coiled-coil domain containing 69 | 2 | 2 | ||||||||
MIRT646833 | TLDC1 | TBC/LysM-associated domain containing 1 | 2 | 2 | ||||||||
MIRT648206 | TRIM35 | tripartite motif containing 35 | 2 | 2 | ||||||||
MIRT648265 | ZNF582 | zinc finger protein 582 | 2 | 2 | ||||||||
MIRT648858 | PDLIM3 | PDZ and LIM domain 3 | 2 | 2 | ||||||||
MIRT648891 | TUBGCP5 | tubulin gamma complex associated protein 5 | 2 | 2 | ||||||||
MIRT649726 | LTBP2 | latent transforming growth factor beta binding protein 2 | 2 | 2 | ||||||||
MIRT649819 | PSMC1 | proteasome 26S subunit, ATPase 1 | 2 | 2 | ||||||||
MIRT652357 | TMEM92 | transmembrane protein 92 | 2 | 2 | ||||||||
MIRT652915 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT654054 | S1PR1 | sphingosine-1-phosphate receptor 1 | 2 | 2 | ||||||||
MIRT654130 | RPL14 | ribosomal protein L14 | 2 | 2 | ||||||||
MIRT654374 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT654503 | RABIF | RAB interacting factor | 2 | 2 | ||||||||
MIRT655743 | NR2F2 | nuclear receptor subfamily 2 group F member 2 | 2 | 2 | ||||||||
MIRT656543 | MACC1 | MACC1, MET transcriptional regulator | 2 | 2 | ||||||||
MIRT656863 | KIN | Kin17 DNA and RNA binding protein | 2 | 2 | ||||||||
MIRT657233 | IER5 | immediate early response 5 | 2 | 2 | ||||||||
MIRT657464 | C21orf33 | chromosome 21 open reading frame 33 | 2 | 2 | ||||||||
MIRT658243 | FAXC | failed axon connections homolog | 2 | 2 | ||||||||
MIRT658456 | FAM13B | family with sequence similarity 13 member B | 2 | 2 | ||||||||
MIRT658510 | ETV3 | ETS variant 3 | 2 | 2 | ||||||||
MIRT658574 | EPHB2 | EPH receptor B2 | 2 | 2 | ||||||||
MIRT659000 | DIAPH1 | diaphanous related formin 1 | 2 | 2 | ||||||||
MIRT659642 | CDK2 | cyclin dependent kinase 2 | 2 | 2 | ||||||||
MIRT660330 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT660803 | AIFM2 | apoptosis inducing factor, mitochondria associated 2 | 2 | 2 | ||||||||
MIRT660990 | ABHD2 | abhydrolase domain containing 2 | 2 | 2 | ||||||||
MIRT662980 | PAK3 | p21 (RAC1) activated kinase 3 | 2 | 2 | ||||||||
MIRT663208 | DARS2 | aspartyl-tRNA synthetase 2, mitochondrial | 2 | 2 | ||||||||
MIRT664535 | EXOG | exo/endonuclease G | 2 | 2 | ||||||||
MIRT666119 | SRRM4 | serine/arginine repetitive matrix 4 | 2 | 2 | ||||||||
MIRT668146 | GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | 2 | 2 | ||||||||
MIRT668831 | CYCS | cytochrome c, somatic | 2 | 2 | ||||||||
MIRT673401 | WNT7B | Wnt family member 7B | 2 | 2 | ||||||||
MIRT676356 | ZNF844 | zinc finger protein 844 | 2 | 2 | ||||||||
MIRT676442 | PLEKHM3 | pleckstrin homology domain containing M3 | 2 | 2 | ||||||||
MIRT683417 | ZNF878 | zinc finger protein 878 | 2 | 2 | ||||||||
MIRT686353 | USP15 | ubiquitin specific peptidase 15 | 2 | 2 | ||||||||
MIRT690686 | PTCHD3 | patched domain containing 3 | 2 | 2 | ||||||||
MIRT696043 | KCNK6 | potassium two pore domain channel subfamily K member 6 | 2 | 2 | ||||||||
MIRT700854 | PERP | PERP, TP53 apoptosis effector | 2 | 2 | ||||||||
MIRT709639 | C2orf91 | chromosome 2 open reading frame 91 | 2 | 2 | ||||||||
MIRT709956 | TRUB2 | TruB pseudouridine synthase family member 2 | 2 | 2 | ||||||||
MIRT711652 | RAB21 | RAB21, member RAS oncogene family | 2 | 2 | ||||||||
MIRT711847 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT713388 | NLN | neurolysin | 2 | 2 | ||||||||
MIRT713933 | PIGR | polymeric immunoglobulin receptor | 2 | 2 | ||||||||
MIRT714991 | TSPAN11 | tetraspanin 11 | 2 | 2 | ||||||||
MIRT715728 | PIAS2 | protein inhibitor of activated STAT 2 | 2 | 2 | ||||||||
MIRT716050 | GRAMD1B | GRAM domain containing 1B | 2 | 2 | ||||||||
MIRT717141 | DLEU1 | deleted in lymphocytic leukemia 1 (non-protein coding) | 2 | 2 | ||||||||
MIRT717412 | ZCCHC24 | zinc finger CCHC-type containing 24 | 2 | 2 | ||||||||
MIRT717525 | GATAD2B | GATA zinc finger domain containing 2B | 2 | 2 | ||||||||
MIRT717914 | LRRC15 | leucine rich repeat containing 15 | 2 | 2 | ||||||||
MIRT717969 | PXMP4 | peroxisomal membrane protein 4 | 2 | 2 | ||||||||
MIRT718742 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 2 | ||||||||
MIRT719096 | PCYT1A | phosphate cytidylyltransferase 1, choline, alpha | 2 | 2 | ||||||||
MIRT719142 | DPYSL5 | dihydropyrimidinase like 5 | 2 | 2 | ||||||||
MIRT719221 | CAMK4 | calcium/calmodulin dependent protein kinase IV | 2 | 2 | ||||||||
MIRT719524 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT719921 | PRKAB1 | protein kinase AMP-activated non-catalytic subunit beta 1 | 2 | 2 | ||||||||
MIRT720324 | CAMK2G | calcium/calmodulin dependent protein kinase II gamma | 2 | 2 | ||||||||
MIRT720719 | RAPGEF6 | Rap guanine nucleotide exchange factor 6 | 2 | 2 | ||||||||
MIRT721636 | MYLK3 | myosin light chain kinase 3 | 2 | 2 | ||||||||
MIRT722611 | TEAD1 | TEA domain transcription factor 1 | 2 | 2 | ||||||||
MIRT724381 | NEK8 | NIMA related kinase 8 | 2 | 2 | ||||||||
MIRT724526 | ATP2B1 | ATPase plasma membrane Ca2+ transporting 1 | 2 | 2 | ||||||||
MIRT725454 | HIPK3 | homeodomain interacting protein kinase 3 | 2 | 2 | ||||||||
MIRT725549 | DNMT3A | DNA methyltransferase 3 alpha | 2 | 2 | ||||||||
MIRT725637 | BTBD9 | BTB domain containing 9 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|